Trials / Completed
CompletedNCT01334619
Ropivacaine Volume for Ultrasound-guided Retrograde Infraclavicular Brachial Plexus Block
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Beijing Jishuitan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The retrograde infraclavicular brachial plexus block has been proved an effective and safe approach. Realtime ultrasound guide will facilitate a successful peripheral nerve block. The purpose of this study was to determine the medium effective volume required to produce an effective retrograde infraclavicular block using an ultrasound (US)-guided technique.
Detailed description
Thirty adults undergoing elective upper limb surgery received an US-guided retrograde infraclavicular block. The initial concentration of 0.5% ropivacaine injected was 30 ml, which was subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient. The medium effective volume (EV50) was determined using the Dixon and Massey up-and-down method. The effective volume in 95% of patients (EV95) was calculated using probit regression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | appropriate volume of 0.5% ropivacaine | initial concentration: 30 ml, subsequently varied at a ratio of 1: 1.2 for each consecutive patient according to the response of the previous patient, until 5 up-and-down cycles completed. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-04-01
- Completion
- 2010-05-01
- First posted
- 2011-04-13
- Last updated
- 2011-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01334619. Inclusion in this directory is not an endorsement.